| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 665,800 | 718,300 | 734,700 | 837,700 | | Cost of Revenue | 590,200 | 644,300 | 643,500 | 719,800 | | | Gross Profit | 75,600 | 74,000 | 91,200 | 117,900 | | | Operating Expenses | | Research Development | 19,500 | 21,300 | 23,900 | 25,100 | | Selling General and Administrative | 136,700 | 162,600 | 155,200 | 82,300 | | Non Recurring | 28,800 | 35,500 | 39,600 | 48,900 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (109,400) | (145,400) | (127,500) | (38,400) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 800 | (900) | (2,900) | | Earnings Before Interest And Taxes | (112,200) | (148,700) | (131,600) | (44,900) | | Interest Expense | 23,700 | 18,300 | 18,200 | 18,600 | | Income Before Tax | (135,900) | (167,000) | (149,800) | (63,500) | | Income Tax Expense | (21,600) | (3,300) | 34,400 | 2,800 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (125,400) | (163,700) | (184,200) | (66,300) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (114,300) | (163,700) | (184,200) | (66,300) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($114,300) | ($163,700) | ($184,200) | ($66,300) |
|
1.52% Nasdaq 
Income Statement
